The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

NA
Marine Biotechnology
Aquaculture
Vaccination against intracellular bacterial pathogens for aquaculture.
National Programme
National
Hanne C. Winther-Larsen
hannewi@farmasi.uio.no
UiO - University of Oslo (Norway)
NA
2014
2017
€ 957,000
https://prosjektbanken.forskningsradet.no/en/project/FORISS/233849?Kilde=FORISS&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=270&TemaEmne.2=Marin+bioteknologi&source=FORISS&projectId=303149
The project will investigate newly discovered vaccine candidates (VC) against infections by two intracellular bacterial pathogens causing major problems in aquaculture, namely Piscirickettsia salmonis and Francisella noatunensis. F. noatunensis sp is one of the main factors hampering the development of fish farming based on Atlantic cod in Norway and is deleterious in tilapia, a fish that is cultured by over 3.5 mill tons/year world wide. P. salmonis infections have been devastating to culturing of salmon ids in Chile. As of today no effective treatments are available against the diseases. One of our VCs has already been tested effective in our newly established Zebrafish infection model system and is ready for vaccine trial experiments in cod. The two oth er candidates need further isolation and characterization before it can be tested in salmonids and tilapia. If the VCs cause immunity in the fish species in question it will have huge market potential for fish vaccine production in which Norway is world leading. Moreover, the vaccines will improve the health of the fish and will greatly impact the outcome from the fish farming industry based on cod, salmonids and tilapia. The intracellular nature of Francisella and Piscirickettsia have up until now compli cated the development of protective measures much unlike efficient vaccines against important extracellular bacterial infections in salmon based on whole inactivated bacteria injected with oil adjuvants. Live attenuated vaccines, most easily established by genetically modification, have proved the most efficient against intracellular pathogens. However, the used of GMO for vaccines purposes are highly regulated and restricted. The new non-GMO based discovery described in this project aim to solve this problem.
Engineering; Bacteria; Vaccines development; Cod; Fish; Genetic;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */